REFI
IOVA icon

Requisite Energy Fund I’s Iovance Biotherapeutics IOVA Stock Holding History

Requisite Energy Fund I’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1.33M Buy
+150,000
New +$1.45M 0.52% 22

Other funds holding IOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Requisite Energy Fund I's IOVA Position: Q4 2018 in Review

Requisite Energy Fund I opened a new position in Iovance Biotherapeutics (IOVA) in Q4 2018: 150,000 shares worth $1.33M. The stake represents 0.52% of the portfolio and ranks #22 among its holdings.

139 funds tracked by Wall St. Rank hold IOVA as of Q4 2018.

  • Requisite Energy Fund I held 150,000 shares of Iovance Biotherapeutics worth $1.33M as of Q4 2018.
  • Iovance Biotherapeutics was a new Requisite Energy Fund I position in Q4 2018.
  • Iovance Biotherapeutics made up 0.52% of Requisite Energy Fund I's portfolio in Q4 2018, its #22 holding.
  • 139 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2018.

Based on Requisite Energy Fund I's 13F filing for Q4 2018, filed 14 Feb 2019.